When the systems stop working: ADHD and the menopause transition

Unsplash: Daria Trofomova

When something that has worked for years stops working, most of us reach for the same explanation. We assume we have gotten slack. That we are not trying hard enough, that we have let our standards slip. So we do the obvious thing and try harder.

If you have known about your ADHD for a long time, you have probably built a life that runs on systems. The lists, the alarms, the routines, the quiet workarounds that hold the week together. For years they hold. Then, somewhere in your forties, they start to slip. Things fall through that never used to fall through, and the familiar verdict arrives: you have let your habits slide, and you need to tighten everything. So you do. More lists, more effort, more willpower poured into the same scaffolding. It does not help, which reads as further proof that the problem is you.

There is another explanation, and it has nothing to do with effort. The strategies did not fail because you stopped trying. They started failing because the ground underneath them moved. The hormonal support your attention system had quietly drawn on for years began to shift with the menopause transition, and traits that were already there became harder to manage. Nothing about you broke. The conditions changed.

One thing to say plainly before going further. Menopause is not only a woman's experience. Trans men, non-binary people, and others assigned female at birth move through the transition too. Most of the research is still framed around women, so that is the word it uses below when it reports what a study measured. What happens to an ADHD nervous system here belongs to anyone who relied on that hormonal support.

Why the old strategies stop holding

The strategies stop holding because they were built on top of something that had always been doing quiet work in the background. Oestrogen is not only a reproductive hormone. In the brain it helps regulate dopamine, and dopamine is central to the systems ADHD already strains: attention, working memory, motivation, the capacity to start a task and hold a plan in mind. If you have ADHD, dopamine signalling is already running on a narrower margin. Anything that supports it is doing more work than it appears to be doing.

Across the menopause transition, oestrogen does not simply fall. It fluctuates, often steeply, before settling at a lower level. As it does, the dopamine systems it helped stabilise lose some of their support, and the traits that lean on those systems become harder to manage (Kooij et al., 2025). The scaffolding you built did not weaken. The neurochemistry it was resting on did.

This is not the first time your attention has moved with your hormones, even if you never connected the two. Many people with ADHD who menstruate already notice their focus and their response to medication shift across the monthly cycle, often worse in the days before a period when oestrogen drops (Wynchank et al., 2025). Perimenopause is the same mechanism stretched out and made unpredictable. What used to be one difficult week a month becomes a moving target with no reliable return.

The strategies did not fail because you stopped trying. They failed because the support holding them up began to move, and an attention system already running on a narrow margin feels that first.

Why the name often arrives in midlife

Not everyone reading this knows they have ADHD. For many people, midlife is the first time the word enters the room. They reached their forties by working harder than the people around them, leaning on intelligence, anxiety, structure, and other people's patience to stay on top of things. Those compensations held while the hormonal support held. When that support shifts, the compensations stop being enough, and traits that were always there finally become visible.

This fits what the research describes across the lifespan. The way ADHD shows up changes with each major hormonal stage, from puberty to the monthly cycle to pregnancy (Osianlis et al., 2025). Noticing your attention for the first time at forty-eight is not developing ADHD. It is meeting, late, something that was there the whole time.

Finding this out in midlife is its own particular experience. There is relief in finally having an explanation that is not "I am lazy" or "I am losing my mind." There is also grief, often, for the years spent assuming the problem was a personal flaw. Both belong.

A late name for a lifelong experience is not a diagnosis arriving too late. It is language arriving at the point where it can finally be used.

What the evidence can and cannot say

It would be easy to overstate all of this. So it is worth being precise about what the research has established and what it has not. The mechanism is well grounded. The lived accounts are consistent and numerous. But the direct study of ADHD during the menopause transition is, at the time of writing, almost absent. The same Australian systematic review that maps hormonal influence across the lifespan states plainly that it found no empirical studies examining ADHD specifically during menopause (Osianlis et al., 2025). What we have is strong mechanism and strong clinical observation, not yet a body of controlled trials.

What the population data do show is a real signal around symptom burden. In a large cohort study, women with ADHD reported severe perimenopausal symptoms at close to twice the rate of women without ADHD (Jakobsdóttir Smári et al., 2025). Whatever is happening here, it is not a handful of individual stories. It shows up at the level of populations.

The picture is not perfectly tidy, and the honest version says so. At least one study found that women with diagnosed ADHD did not rate their menopausal symptoms as uniformly worse at every stage (Chapman et al., 2025). How hormonal change, ADHD traits, and the way a person reads their own experience fit together is layered, not linear. Holding that complexity is part of taking the question seriously instead of selling a clean answer.

The mechanism is solid and the lived experience is consistent. Controlled research on ADHD during menopause barely exists yet. The honest position is a strong hypothesis, not a settled fact.

How this changes the way we read the struggle

Once the struggle is read this way, the response changes. The instinct to tighten the same failing strategies, to demand more willpower from a system that is already overdrawn, stops making sense. The more useful questions are different ones. Where is your energy actually going. Which supports moved. What can be rebuilt around a nervous system whose conditions have changed, rather than against it.

Some of that work is medical and sits outside psychology, and it is rarely owned by one clinician alone. Menopause hormone therapy usually sits with a GP, while ADHD medication often sits with a psychiatrist. Both act on the same nervous system at the same time. That works best when the GP and the psychiatrist are in contact with each other, not prescribing in parallel. You stay at the centre of the conversation, rather than carrying messages between them.

If you have spent decades being told you are careless or scattered, the hardest part is often not the logistics. It is letting go of the verdict you reached about yourself long ago. That verdict was always wrong. The traits were never the failure, and the loss of support was never a loss of character. The conditions changed, and conditions can be worked with.

References

Chapman, L., Gupta, K., Hunter, M. S., & Dommett, E. J. (2025). Examining the link between ADHD symptoms and menopausal experiences. Journal of Attention Disorders, 29(14), 1263–1277. https://doi.org/10.1177/10870547251355006

Jakobsdóttir Smári, U., Valdimarsdottir, U. A., Wynchank, D., de Jong, M., Aspelund, T., Hauksdottir, A., Thordardottir, E. B., Tomasson, G., Jakobsdottir, J., Lu, D., Nevriana, A., Larsson, H., Kooij, S., & Zoega, H. (2025). Perimenopausal symptoms in women with and without ADHD: A population-based cohort study. European Psychiatry, 68(1), Article e133. https://doi.org/10.1192/j.eurpsy.2025.10101

Kooij, J. J. S., de Jong, M., Agnew-Blais, J., Amoretti, S., Bang Madsen, K., Barclay, I., Bölte, S., Borg Skoglund, C., Broughton, T., Carucci, S., van Dijken, D. K. E., Ernst, J., French, B., Frick, M. A., Galera, C., Groenman, A. P., Kopp Kallner, H., Kerner auch Koerner, J., Kittel-Schneider, S., . . . Wynchank, D. (2025). Research advances and future directions in female ADHD: The lifelong interplay of hormonal fluctuations with mood, cognition, and disease. Frontiers in Global Women's Health, 6, Article 1613628. https://doi.org/10.3389/fgwh.2025.1613628

Osianlis, E., Thomas, E. H. X., Jenkins, L. M., & Gurvich, C. (2025). ADHD and sex hormones in females: A systematic review. Journal of Attention Disorders, 29(9), 706–723. https://doi.org/10.1177/10870547251332319

Wynchank, D., Sutrisno, R. M. G. T. M. F., van Andel, E., & Kooij, J. J. S. (2025). Menstrual cycle-related hormonal fluctuations in ADHD: Effect on cognitive functioning: A narrative review. Journal of Clinical Medicine, 15(1), Article 121. https://doi.org/10.3390/jcm15010121

Disclaimer: The information provided in this blog post is for educational and informational purposes only and is not a substitute for professional psychological or medical advice. This topic can be personal, and if it raises something for you, support is available. The content is intended to support general wellbeing and personal growth, but it may not address specific individual needs. If you have mental health concerns or require personalised support, please consult a qualified healthcare provider. If you are in crisis, please contact Lifeline on 13 11 14 or Beyond Blue on 1300 22 4636. Equal Psychology and its authors are not liable for any actions taken based on this information.